Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative analysis between abdominal aortic aneurysm and popliteal artery aneurysm. | JVS Vasc Sci | 2025 | 39944078 | PubTator, text mining | PubMed |
KLF12 inhibits lipopolysaccharide-induced inflammatory responses, oxidative stress, pyroptosis, and endoplasmic reticulum stress in human airway epithelial cells through inhibition of the NF-κB pathway. | Biochim Biophys Acta Mol Cell Res | 2025 | 39938687 | PubTator, text mining | PubMed |
| The miR-1305/KLF5 negative regulatory loop affects pancreatic cancer cell proliferation and apoptosis. | Hum Cell | 2025 | 39921786 | PubTator, text mining | PubMed |
| KLF5 promotes esophageal squamous cell carcinoma radioresistance by targeting the Keap1-Nrf2 pathway. | Discov Oncol | 2025 | 39918680 | PubTator, text mining | PubMed |
| Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer. | Proc Natl Acad Sci U S A | 2025 | 39913208 | PubTator, text mining | PubMed |
| Correction: BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression. | Oncogene | 2025 | 39900726 | PubTator, text mining | PubMed |
| Epigenetic mechanisms regulating CD8+ T cell senescence in aging humans. | bioRxiv | 2025 | 39896543 | PubTator, text mining | PubMed |
| Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer. | Adv Sci (Weinh) | 2025 | 39888288 | PubTator, text mining | PubMed |
| A Regulatory Circuits Analysis Tool, "miRCuit," Helps Reveal Breast Cancer Pathways: Toward Systems Medicine in Oncology. | OMICS | 2025 | 39853230 | PubTator, text mining | PubMed |
| LncRNA-HHCP5 Regulates KLF5 in ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis. | Int J Rheum Dis | 2025 | 39835513 | PubTator, text mining | PubMed |
| Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells. | Cell Death Dis | 2025 | 39827156 | PubTator, text mining | PubMed |
| KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency. | Nat Commun | 2025 | 39779698 | PubTator, text mining | PubMed |
| Fatty acid desaturase 2 (FADS2) affects the pluripotency of hESCs by regulating energy metabolism. | Int J Biol Macromol | 2025 | 39756764 | PubTator, text mining | PubMed |
| Pan-cancer drivers of metastasis. | Mol Cancer | 2025 | 39748426 | PubTator, text mining | PubMed |
| M2-polarized tumor-associated macrophage-secreted exosomal lncRNA NEAT1 upregulates galectin-3 by recruiting KLF5 and promotes HCC immune escape. | J Cell Commun Signal | 2025 | 39720765 | PubTator, text mining | PubMed |
| Suppression of KLF5 targets RREB1 to restrain the proliferation of ovarian cancer cells through ERK/MAPK signaling pathway. | 3 Biotech | 2025 | 39676889 | PubTator, text mining | PubMed |
| Systematic drug screening and target analysis identify digitoxin as a potential therapy for uveal melanoma. | Br J Pharmacol | 2025 | 39617007 | PubTator, text mining | PubMed |
| KLF5 Shapes Developing Respiratory Tubules by Inhibiting Actin Asymmetry in Epithelial Cells. | Am J Respir Cell Mol Biol | 2025 | 39556252 | PubTator, text mining | PubMed |
| Investigating the dysregulation of genes associated with glucose and lipid metabolism in gastric cancer and their influence on immunity and prognosis. | Biofactors | 2025 | 39508713 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomics reveals subsets of degenerative myonuclei after rotator cuff tear-induced muscle atrophy. | Cell Prolif | 2025 | 39435630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=10